Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress

Diabetes Research and Clinical Practice

Volumn 104, Issue 1, 2014, Pages 143-154

  Lv, Shasha ^a   Cheng, Jing ^a   Sun, Aili ^a   Li, Junhua ^b   Wang, Weiwei ^a   Guan, Guangju ^a   Liu, Gang ^a   Su, Moran ^c  

^a SHANDONG UNIVERSITY   (China)

^b Department of Laboratory People's Hospital of Ling County   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Bone marrow mesenchymal stem cells; Diabetic nephropathy; Glucose transporter Type 1; Hepatocyte growth factor; Oxidative stress

Indexed keywords

COLLAGEN TYPE 1; CREATININE; GLUCOSE TRANSPORTER 1; INSULIN; PROBUCOL; REACTIVE OXYGEN METABOLITE; SCATTER FACTOR; SCLEROPROTEIN; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA; ANTIOXIDANT; GLUCOSE BLOOD LEVEL;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CREATININE CLEARANCE; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GLOMERULOSCLEROSIS; GLUCOSE BLOOD LEVEL; KIDNEY MASS; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT; SIGNAL TRANSDUCTION; ANIMAL; BLOOD; CELL CULTURE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; GLOMERULUS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROCEDURES; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; FEMALE; KIDNEY GLOMERULUS; MESENCHYMAL STEM CELL TRANSPLANTATION; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 84898539820     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.01.011     Document Type: Article

References (50)

1. Collins A.J., Foley R.N., Herzog C., Chavers B., Gilbertson D., Ishani A., et al. US Renal Data System 2012 Annual Data Report. Am J Kidney Dis 2013, 61. A7, e1-476.
2. Collins A.J., Foley R.N., Gilbertson D.T., Chen S.-C. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol 2009, 4:S5-S11.
3. Coresh J., Byrd-Holt D., Astor B.C., Briggs J.P., Eggers P.W., Lacher D.A., et al. Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000. J Am Soc Nephrol 2005, 16:180-188.
4. Wolfe R.A., Ashby V.B., Milford E.L., Ojo A.O., Ettenger R.E., Agodoa L.Y., et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999, 341:1725-1730.
5. Yamagishi S.-i. Role of advanced glycation end products (AGEs) and receptor for ages (RAGE) in vascular damage in diabetes. Exp Gerontol 2011, 46:217-224.
6. Giacco F., Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010, 107:1058-1070.
7. Nishikawa T., Araki E. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal 2007, 9:343-353.
8. Yamagishi S.-i., Maeda S., Matsui T., Ueda S., Fukami K., Okuda S. Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes. Biochim Biophys Acta 2012, 1820:663-671.
9. Forbes J.M., Coughlan M.T., Cooper M.E. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008, 57:1446-1454.
10. Ha H., Lee H.B. Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int 2000, 58:S19-S25.
11. Ziyadeh F.N., Sharma K., Ericksen M., Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 1994, 93:536-542.
12. Oh J.H., Ha H., Yu M.R., Lee H.B. Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis. Kidney Int 1998, 54:1872-1878.
13. Ayo S.H., Radnik R.A., Garoni J.A., Glass W.F. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 1990, 136:1339-1348.
14. Iglesias-de la Cruz M.C., Ruiz-Torres P., Alcamí J., Díez-Marqués L., Ortega-Velázquez R., Chen S., et al. Hydrogen peroxide increases extracellular matrix mRNA through TGF-βin human mesangial cells. Kidney Int 2001, 59:87-95.
15. Ha H., Lee H.B. Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney. Nephrology 2005, 10:S7-S10.
16. Wang Y., Heilig K., Saunders T., Minto A., Deb D.K., Chang A., et al. Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis. Am J Physiol Renal Physiol 2010, 299:F99-F111.
17. Linden K.C., DeHaan C.L., Zhang Y., Glowacka S., Cox A.J., Kelly D.J., et al. Renal expression and localization of the facilitative glucose transporters GLUT1 and GLUT12 in animal models of hypertension and diabetic nephropathy. Am J Physiol Renal Physiol 2006, 290. F205-F13.
18. Gnudi L., Viberti G., Raij L., Rodriguez V., Burt D., Cortes P., et al. GLUT-1 overexpression link between hemodynamic and metabolic factors in glomerular injury. Hypertension 2003, 42:19-24.
19. Morigi M., Introna M., Imberti B., Corna D., Abbate M., Rota C., et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 2008, 26:2075-2082.
20. Morigi M., Imberti B., Zoja C., Corna D., Tomasoni S., Abbate M., et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 2004, 15:1794-1804.
21. Semedo P., Correa-Costa M., Antonio Cenedeze M., Maria Avancini Costa Malheiros D., Antonia dos Reis M., Shimizu M.H., et al. Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. Stem Cells 2009, 27:3063-3073.
22. Kunter U., Rong S., Djuric Z., Boor P., Müller-Newen G., Yu D., et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol 2006, 17:2202-2212.
23. Tögel F., Westenfelder C. Adult bone marrow-derived stem cells for organ regeneration and repair. Dev Dyn 2007, 236:3321-3331.
24. Ezquer F.E., Ezquer M.E., Parrau D.B., Carpio D., Yañez A.J., Conget P.A. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transplant 2008, 14:631-640.
25. Lee R.H., Seo M.J., Reger R.L., Spees J.L., Pulin A.A., Olson S.D., et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci 2006, 103:17438-17443.
26. Ezquer F., Ezquer M., Simon V., Pardo F., Yañez A., Carpio D., et al. Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice. Biol Blood Marrow Transplant 2009, 15:1354-1365.
27. Wang S., Li Y., Zhao J., Zhang J., Huang Y. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model. Biol Blood Marrow Transplant 2013, 19:538-546.
28. Ho J.H., Tseng T.-C., Ma W.-H., Ong W.-K., Chen Y.-F., Chen M.-H., et al. Multiple intravenous transplantations of mesenchymal stem cells effectively restore long-term blood glucose homeostasis by hepatic engraftment and -cell differentiation in streptozocin-induced diabetic mice. Cell Transpl 2012, 21:997-1009.
29. Lv S.-S., Liu G., Wang J.-P., Wang W.-W., Cheng J., Sun A.-L., et al. Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltration. Int Immunopharmacol 2013, 17:275-282.
30. Koya D., Hayashi K., Kitada M., Kashiwagi A., Kikkawa R., Haneda M. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol 2003, 14:S250-S253.
31. Si Y., Zhao Y., Hao H., Liu J., Guo Y., Mu Y., et al. Infusion of mesenchymal stem cells ameliorates hyperglycemia in Type 2 diabetic rats identification of a novel role in improving insulin sensitivity. Diabetes 2012, 61:1616-1625.
32. Lindoso R.S., Araujo D.S., Adão-Novaes J., Mariante R.M., Verdoorn K.S., Fragel-Madeira L., et al. Paracrine interaction between bone marrow-derived stem cells and renal epithelial cells. Cell Physiol Biochem 2011, 28:267-278.
33. Inoki K., Haneda M., Maeda S., Koya D., Kikkawa R. TGF-β1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells. Kidney Int 1999, 55:1704-1712.
34. Tesch G.H., Allen T.J. Rodent models of streptozotocin-induced diabetic nephropathy (Methods in Renal Research). Nephrology 2007, 12:261-266.
35. Liu C.X., Hu Q., Wang Y., Zhang W., Ma Z.Y., Feng J.B., et al. Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition. Mol Med 2011, 17:59-69.
36. Kita T., Nagano Y., Yokode M., Ishii K., Kume N., Narumiya S., et al. Prevention of atherosclerotic progression in Watanabe rabbits by probucol. Am J Cardiol 1988, 62:B13-B19.
37. Parthasarathy S., Young S.G., Witztum J.L., Pittman R.C., Steinberg D. Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest 1986, 77:641.
38. Endo K., Saiki A., Yamaguchi T., Sakuma K., Sasaki H., Ban N., et al. Probucol suppresses initiation of chronic hemodialysis therapy and renal dysfunction-related death in diabeticnephropathy patients: Sakura study. J Atheroscler Thromb 2013, 20:494-502.
39. Kashihara N., Haruna Y., Kondeti K.V., Kanwar S.Y. Oxidative stress in diabetic nephropathy. Curr Med Chem 2010, 17:4256-4269.
40. Ianus A., Holz G.G., Theise N.D., Hussain M.A. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 2003, 111:843-850.
41. Hess D., Li L., Martin M., Sakano S., Hill D., Strutt B., et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 2003, 21:763-770.
42. Ha H., Yu M.R., Choi Y.J., Kitamura M., Lee H.B. Role of high glucose-induced nuclear factor-κB activation in monocyte chemoattractant protein-1 expression by mesangial cells. J Am Soc Nephrol 2002, 13:894-902.
43. Coward R.J., Welsh G.I., Yang J., Tasman C., Lennon R., Koziell A., et al. The human glomerular podocyte is a novel target for insulin action. Diabetes 2005, 54:3095-3102.
44. Li J.H., Huang X.R., Zhu H.-J., Johnson R., Lan H.Y. Role of TGF-β signaling in extracellular matrix production under high glucose conditions. Kidney Int 2003, 63:2010-2019.
45. Reeves W.B., Andreoli T.E. Transforming growth factor β contributes to progressive diabetic nephropathy. Proc Natl Acad Sci 2000, 97:7667-7669.
46. Basile D.P. Transforming growth factor-beta as a target for treatment in diabetic nephropathy. Am J Kidney Dis 2001, 38:887-892.
47. Gambaro G., Ceol M., Del Prete D., D'Angelo A. GLUT-1 and TGF-β: the link between hyperglycaemia and diabetic nephropathy. Nephrol Dial Transplant 2000, 15:1476-1477.
48. Ishikane S., Ohnishi S., Yamahara K., Sada M., Harada K., Mishima K., et al. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia. Stem Cells 2008, 26:2625-2633.
49. Mizuno S., Nakamura T. Suppressions of chronic glomerular injuries and TGF-β1 production by HGF in attenuation of murine diabetic nephropathy. Am J Physiol Renal Physiol 2004, 286:F134-F143.
50. Dai C., Liu Y. Hepatocyte growth factor antagonizes the profibrotic action of TGF-β1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF. J Am Soc Nephrol 2004, 15:1402-1412.